ArticleOrphanet journal of rare diseases2026
Genetic and clinical characteristics of pediatric patients with cystic fibrosis: a single-center retrospective study in China.
Article in Orphanet journal of rare diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
backgroundDespite the increasing recognition of cystic fibrosis (CF) in China, few cases have been reported in the Xinjiang Uyghur Autonomous Region (Xinjiang), which is located in China’s northwest with a diverse ethnic composition. This study aimed to describe the genotype and clinical phenotype of children with CF in Xinjiang.
methodsWe recruited children diagnosed with CF at the Children’s Hospital of Xinjiang Uygur Autonomous Region between January 2012 and December 2025. The demographic data, imaging findings, laboratory test results, and genetic data were retrospectively reviewed.
resultsA total of 19 patients from 18 families were enrolled. The median age at diagnosis was 9.8 years. Among them, 15 (78.9%) were Uygur, 3 (15.8%) Kazakh, and 1 (5.3%) Mongolian. Fifteen distinct cystic fibrosis transmembrane conductance regulator (CFTR) mutations were identified, with c.1521_1523delCTT (p. F508del) being the most common (allele frequency: 36.1%). Mutations of c.1860T > G (p.H620Q), c.2991 G > C (p.L997F), del ex4-11, c.3254 A > G (p.H1085R), c.2619 + 1G > A, c.349 C > T (p.R117C), c.3909 C > G (p.N1303K), and c.1911delA > G (p.G637Hfs*26)—which have never been reported in Chinese populations—were observed. Bronchiectasis was observed in 84.2% of patients, with allergic bronchopulmonary aspergillosis noted in 36.8%. Pseudomonas aeruginosa (78.9%) and Staphylococcus aureus (47.4%) were the predominant pathogens. Additionally, 78.9% had pancreatic insufficiency, 21.1% had CF-related liver disease, 21.1% had Pseudo-Bartter syndrome, and 5.3% had diabetes.
conclusionCF may be significantly underdiagnosed in Xinjiang, China. The genotypic spectrum in children with CF in this multiethnic region differs considerably from previous reports, mainly focusing on the Han population, with p.F508del as the most frequent CFTR mutation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.